Dergiler / Acta Medica / 2018 / Cilt: 49 - Sayı: 1

Regulatory Role of Chemerin in Lung Tumorigenesis and Cancer-associated Inflammation

Sayfa
16–25
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Chemerin may possess a potential to modulate the inflammatory re- sponses in the tumor microenvironment.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Interaction between the chemokine-like receptor 1 (CMKLR1) and its cog- nate peptide ligand, chemerin, can downregulate the inflammatory responses.
📊
Temel Bulgular & Veri:Results: CMKLR1 was identified in mouse LLC tumors.
💡
Sonuç & Katkı:Conclusion: Chemerin may possess a potential to modulate the inflammatory re- sponses in the tumor microenvironment.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Interaction between the chemokine-like receptor 1 (CMKLR1) and its cog- nate peptide ligand, chemerin, can downregulate the inflammatory responses. This study investigates the regulatory role chemerin in lung tumorigenesis and cancer-as- sociated inflammation. Materials and methods: Animal experiments, cell culture, gene cloning and transfec- tion, chemotaxis assay, Lewis lung carcinoma (LLC) tumorigenesis assays, histopatho- logical evaluation, mixed leukocyte reactions, flow cytometry, proliferation and clo- nogenicity assays, reverse transcription-polymerase chain reaction (RT-PCR), en- zyme-linked immunosorbent assay (ELISA), and immunohistochemistry (IHC) tech- niques were used. Results: CMKLR1 was identified in mouse LLC tumors. The LLC cells were modified to secrete prochemerin at a level that cannot induce chemotactic activity. Inflammatory cytokine expression, TNF-α, IL-12 p40, but not IL-1β, was diminished in leukocytes when exposed to conditioned media obtained from the chemerin-expressing LLC cells, and in the tumors established with those cells. On the other hand, leukocyte proliferation and IFN-γ expression were not drastically impeded. Correspondingly, tu- mor forming capacity of the chemerin-expressing LLCs was decreased. Conclusion: Chemerin may possess a potential to modulate the inflammatory re- sponses in the tumor microenvironment.

🔖

Bu Makaleye Atıf Yap

UNVER, N., YILMAZ, G. E., CANPİNA, H., GÜÇ, D., ESENDAĞLI, G. (2018). Regulatory Role of Chemerin in Lung Tumorigenesis and Cancer-associated Inflammation. Acta Medica, Cilt: 49 - Sayı: 1, 16–25. https://ajindex.com/articles/144217

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004;22:329-360.
  2. Esendagli G, Bruderek K, Goldmann T et al. Malignant and non-malignant lung tissue areas are differentially popu- lated by natural killer cells and regulatory T cells in non- small cell lung cancer. Lung Cancer 2008;59:32-40.
  3. Koizumi K, Hojo S, Akashi T, Yasumoto K, et al. Chemokine receptors in cancer metastasis and cancer cell-de- rived chemokines in host immune response. Cancer Sci 2007;98:1652-1658. O’Hayre M, Salanga CL, Handel TM, et al. Chemokines and cancer: migration, intracellular signalling and intercellu- lar communication in the microenvironment. Biochem J 2008;409:635-49.
  4. Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003;198:977-985. [6] Zabel BA, Silverio AM, Butcher EC. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis dis- tinguish plasmacytoid from myeloid dendritic cells in hu- man blood. J Immunol 2005;174:244-51.
  5. Vermi W, Riboldi E, Wittamer V, et al. Role of ChemR23 in directing the migration of myeloid and plasmacytoid den- dritic cells to lymphoid organs and inflamed skin. J Exp Med 2005;201:509-915.
  6. Cash JL, Hart R, Russ A, et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 2008;205:767-775.
  7. Campbell EL, Louis NA, Tomassetti SE, et al. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J 2007;21:3162-3170.
  8. Meder W, Wendland M, Busmann A, et al. Characterization of human circulating TIG2 as a ligand for the orphan re- ceptor ChemR23. FEBS Lett 2003;555:495-499.
  9. Zabel BA, Allen SJ, Kulig P, et al. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and in- flammatory cascades. J Biol Chem 2005;280:34661-34666.
  10. Parolini S, Santoro A, Marcenaro E, et al. The role of chem- erin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007;109:3625-3632.
  11. Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a nov- el adipokine associated with obesity and metabolicsyn- drome. Endocrinology 2007;148:4687-94.
  12. Luangsay S, Wittamer V, Bondue B et al. Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model. J Immunol 2009;183:6489-6499.
  13. Weigert J, Obermeier F